logo
Sarepta to pause Elevidys gene therapy shipments in US

Sarepta to pause Elevidys gene therapy shipments in US

Reuters6 days ago
July 21 (Reuters) - Sarepta Therapeutics (SRPT.O), opens new tab said on Monday it will pause all shipments of Elevidys in the United States after two teenage boys with a rare condition called Duchenne muscular dystrophy, who had received the company's gene therapy, died of liver failure this year.
The U.S. Food and Drug Administration on Friday asked Sarepta to voluntarily halt shipments of its gene therapy.
The company responded that it would continue providing the treatment to ambulatory patients — while maintaining a halt it implemented June 15 for non-ambulatory patients.
Sarepta's shares are down 8.6% to $12.17 after the bell. The stock plummeted, opens new tab on Friday after it disclosed the dead of a third patient who had received an experimental gene therapy, deepening investor concerns over the company's treatments.
While the 51-year-old man with limb girdle muscular dystrophy who died most recently was not taking Elevidys, the experimental therapy he took was based on similar gene technology, the FDA said.
The FDA put Sarepta's clinical trials for limb girdle muscular dystrophy on hold due to safety concerns.
All shipments of Elevidys for Duchenne muscular dystrophy will be temporarily paused by close of business on Tuesday, Sarepta said Monday.
The company said that the pause will allow it the "time to respond to any requests for information and allow Sarepta and FDA to complete the Elevidys safety labeling supplement process."
Sarepta said it anticipates a review and dialogue with the FDA.
The FDA did not immediately respond to a Reuters request for comment.
After the first two deaths, Sarepta in June suspended the use of Elevidys for patients whose disease had progressed to the point where they need a wheelchair.
Elevidys has full FDA approval for children with DMD who are still able to walk, and conditional approval for non-ambulatory patients.
Last week, Sarepta said it was adding a warning on Elevidys' label for the risk of acute liver injury and liver failure in DMD patients who can walk. It also announced 500 job cuts and halted development of several gene therapies for limb girdle muscular dystrophy.
Separately, the Children's Hospital Los Angeles, said on Monday it has paused usage of Elevidys in all patients with muscular dystrophy.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Stocks rise, euro firms after US-EU trade agreement
Stocks rise, euro firms after US-EU trade agreement

Reuters

time5 minutes ago

  • Reuters

Stocks rise, euro firms after US-EU trade agreement

SINGAPORE, July 28 (Reuters) - Global stocks rose and the euro firmed on Monday after a tradeagreement between the United States and the EU lifted sentiment and provided some clarity in a week of key policy meetings by the Federal Reserve and the Bank of Japan. The U.S. struck a framework trade agreement with the European Union, imposing a 15% import tariff on most EU goods - half the threatened rate, a week after agreeing to a trade deal with Japan that lowered proposed tariffs on auto imports. Countries are scrambling to finalise trade deals ahead of an August 1 deadline set by U.S. President Donald Trump, with talks between the U.S. and China set for Monday in Stockholm amid expectations of another 90-day extension to the truce between the world's top two economies. "A 15% tariff on European goods, forced purchases of U.S. energy and military equipment and zero tariff retaliation by Europe, that's not negotiation, that's the art of the deal," said Prashant Newnaha, senior Asia-Pacific rates strategist at TD Securities. "A big win for the U.S." S&P 500 futures rose 0.4% and the Nasdaq futures gained 0.5% while the euro firmed across the board, rising against the dollar, sterling and yen. European futures surged nearly 1%. MSCI's broadest index of Asia-Pacific shares outside Japan (.MIAPJ0000PUS), opens new tab was up 0.27%, just shy of the almost four-year high it touched last week. Japan's Nikkei fell 0.8% after hitting a one-year high last week. While the baseline 15% tariff will still be seen by many in Europe as too high, compared with Europe's initial hopes to secure a zero-for-zero tariff deal, it is better than the threatened 30% rate. The U.S.-EU deal provides clarity to companies and averts a bigger trade war between the two allies that account for almost a third of global trade. "A major tail-risk has now been defused," said Marc Velan, head of investments at Lucerne Asset Management in Singapore. "Markets are interpreting this as a sign of stability and predictability returning to trade policy," he added. "The China delay fits the same pattern: the administration is opting for controlled diplomacy over confrontation." China's blue-chip stocks (.CSI300), opens new tab rose 0.3% while the Hong Kong's Hang Seng index (.HSI), opens new tab advanced 0.75%. The Australian dollar , often seen as a proxy for risk appetite, was at $0.657, hovering around the near eight-month peak scaled last week. In an action-packed week, investors will watch out for the monetary policy meetings from the Fed and the BOJ as well as the monthly U.S. employment report and earnings from megacap companies Apple (AAPL.O), opens new tab, Microsoft (MSFT.O), opens new tab and Amazon (AMZN.O), opens new tab. While the Fed and the BOJ are expected to maintain rates, comments from the officials will be crucial for investors to gauge the interest rate path. The trade deal with Japan has opened the door for the BOJ to raise rates again this year. Meanwhile, the Fed is likely to be cautious on any rate cuts as officials seek more data to determine tariffs' impact on inflation before they ease rates further. But tensions between the White House and the central bank over monetary policy have increased, with Trump repeatedly lashing out at Fed Chair Jerome Powell for not cutting rates. Two of the Fed Board's Trump appointees have articulated reasons for supporting a rate cut this month. "Inflation readings, particularly the PCE index, and the upcoming July jobs report will shape expectations beyond this meeting, with the next likely policy pivot now pushed out to September if inflation continues to ease," said Kieran Williams, head of Asia FX at InTouch Capital Markets. In commodities, oil prices rose after the U.S.-EU trade agreement. Brent crude futures and U.S. West Texas Intermediate crude both rose 0.5%. Gold prices fell on Monday to their lowest in nearly two weeks on reduced appetite for safe havens.

Gold falls to near two-week low after US, EU agree to tariff deal
Gold falls to near two-week low after US, EU agree to tariff deal

Reuters

time5 minutes ago

  • Reuters

Gold falls to near two-week low after US, EU agree to tariff deal

July 28 (Reuters) - Gold prices fell to their lowest level in nearly two weeks on Monday, as a framework trade agreement between the United States and European Union ahead of the August 1 tariff deadline boosted appetite for risk assets. Spot gold was down 0.1% at $3,332.18 per ounce, as of 0208 GMT, after touching its lowest level since July 17. U.S. gold futures edged 0.1% lower to $3,331.60. The U.S. struck a framework trade agreement with the European Union on Sunday, imposing a 15% import tariff on most EU goods - half the threatened rate - and averting a bigger trade war between the two allies that account for almost a third of global trade. However, the agreement left key issues unresolved, including tariffs on spirits. The agreement eased transatlantic trade tensions, putting pressure on gold, said Jigar Trivedi, a senior commodity analyst at Reliance Securities, adding that it also softened the dollar index, which provided some cushion to bullion. The U.S. dollar index (.DXY), opens new tab eased 0.1%, making greenback-priced bullion more affordable for overseas buyers. Risk sentiment improved following the agreement, with European currencies and U.S. stock index futures trading higher. Meanwhile, senior U.S. and Chinese negotiators are set to meet in Stockholm later in the day to address long-standing economic disputes, seeking to extend a truce that has prevented higher tariffs. "In the short term, we don't expect gold to experience wild swings. Investors are turning their focus to a pivotal week for U.S. monetary policy and economic data," Trivedi said. The Federal Reserve is expected to maintain its benchmark interest rate in the 4.25%-4.50% range after its two-day policy meeting concludes on Wednesday. U.S. President Donald Trump said on Friday he had a positive meeting with Powell, suggesting the Fed chief might be inclined to lower interest rates. Spot silver was up 0.2% at $38.23 per ounce, while platinum gained 0.6% to $1,409.50 and palladium rose 0.6% to $1,227.76.

Eroding protections for public lands
Eroding protections for public lands

Reuters

timean hour ago

  • Reuters

Eroding protections for public lands

'Public lands have tremendous bipartisan support in the state,' Lawson said in reference to her home state of Montana, about 30% of which is federal public land. 'Everybody from the wilderness advocates who want public land preserved in perpetuity to the hunters and anglers to the OHV (off-highway vehicle) Jeepers. Everybody loves public lands. Access to those public lands is so integral to daily life.' Deep budget and staffing cuts to the U.S. National Forest Service, National Park Service and Bureau of Land Management could affect their ability to effectively care for these lands at a time when they are experiencing record numbers of visitors. Last year, national parks welcomed more than 332 million visitors, a new high, up 6 million from 2023. The National Park System has lost 24% of its permanent staff since Trump returned to office in January, according to the National Parks Conservation Association, a watchdog advocacy group. The association attributes much of the drop to job cuts and staff taking buyouts offered by Trump's administration. And, the National Forest Service cut about 10% of its workforce as part of the administration's campaign to reduce spending. This legislation that Trump signed also rescinded funding for conservation and climate resilience projects in national parks and Bureau of Land Management land that was provided in a law signed by his predecessor Joe Biden called the Inflation Reduction Act. 'Unleashing America's economic potential goes hand-in-hand with preserving our public lands, as years of mismanagement, regulatory overreach and neglect of routine management have hindered outdoor recreation opportunities,' the White House said in a statement to Reuters. Leshy said budget and staffing cuts could be a strategic move by U.S. officials who have long wanted to dispose of public land, pointing to Russell Vought, director of the White House Office of Management and Budget and a force behind the Project 2025 initiative that laid out a conservative blueprint for reshaping the U.S. government. 'I think they've decided, looking at the opinion polls, that it's not popular and it's not wise to press for outright selling off or disposing, transferring federal lands. So what they're doing instead is hollowing out their management, is slashing their budgets and slashing the personnel,' Leshy said. 'The aim is, 'Let's make federal management so bad and so dismal that it will change public opinion,'' Leshy added.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store